IACCARINO, ANTONINO
 Distribuzione geografica
Continente #
NA - Nord America 842
EU - Europa 451
AS - Asia 61
AF - Africa 18
Totale 1.372
Nazione #
US - Stati Uniti d'America 838
IT - Italia 253
DE - Germania 37
NL - Olanda 33
CN - Cina 30
GB - Regno Unito 24
SE - Svezia 19
IE - Irlanda 18
CI - Costa d'Avorio 16
ES - Italia 16
GR - Grecia 15
IN - India 15
FI - Finlandia 11
UA - Ucraina 11
FR - Francia 10
VN - Vietnam 5
CA - Canada 4
PK - Pakistan 4
SG - Singapore 3
BE - Belgio 2
BD - Bangladesh 1
EG - Egitto 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
MD - Moldavia 1
RO - Romania 1
SC - Seychelles 1
Totale 1.372
Città #
Chandler 205
Ashburn 89
Naples 54
Millbury 47
Napoli 47
Lawrence 38
Amsterdam 33
Des Moines 24
Wilmington 20
Boston 17
Heraklion 14
Valencia 14
Beijing 13
Fairfield 10
Nanjing 10
Milan 9
Princeton 7
Rome 7
Salerno 7
Bologna 6
Grosseto 6
Woodbridge 6
Dublin 5
Krefeld 5
Pune 5
Dong Ket 4
Houston 4
Karachi 4
Kronberg 4
Redwood City 4
Washington 4
Bad Durrheim 3
Caserta 3
Helsinki 3
Lappeenranta 3
Montalto di Castro 3
Nanchang 3
Ottawa 3
Pagani 3
Salt Lake City 3
Seattle 3
Singapore 3
Boardman 2
Brindisi 2
Cava Manara 2
Jacksonville 2
Monza 2
New York 2
Pozzuoli 2
Scafati 2
Alatri 1
Angri 1
Ardabil 1
Avellino 1
Aversa 1
Bari 1
Brussels 1
Casoria 1
Castelbuono 1
Cava De' Tirreni 1
Cerro Maggiore 1
Changchun 1
Chennai 1
Chisinau 1
Chittagong 1
Collegno 1
Crispano 1
Dresden 1
Eboli 1
Edinburgh 1
Florence 1
Formia 1
Frankfurt am Main 1
Galati 1
Genoa 1
Genova 1
Greve in Chianti 1
Grezzana 1
Guangzhou 1
Gurgaon 1
Hanoi 1
Hanover 1
Hicksville 1
Indiana 1
Jiaxing 1
Kagoya 1
Lanzhou 1
London 1
Lucca 1
Manchester 1
Mountain View 1
Norwalk 1
Nova Siri 1
Pomigliano D'arco 1
Portland 1
Pozzuolo Martesana 1
San Giorgio A Cremano 1
San Mango Piemonte 1
Santa Maria Capua Vetere 1
Saviano 1
Totale 821
Nome #
Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors 84
Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation 67
Analysis of human primary fibroblast spheroids 61
Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer 55
Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts 50
UbcH10 expression in human lymphomas. 44
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients 41
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 39
Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation 39
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 38
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 34
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 33
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 32
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 30
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 29
The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience 29
UbcH10 expression on thyroid fine-needle aspirates. 27
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 27
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 27
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study 26
Predictive molecular pathology in the time of COVID-19 26
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 26
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 25
Methods for actionable gene fusion detection in lung cancer: now and in the future 25
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 24
Cytology in the time of coronavirus disease (covid-19): An Italian perspective 24
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 24
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 24
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 24
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature 23
BRAF: A Two-Faced Janus 22
Concomitant Rare KRAS and BRAF Mutations in Lung Adenocarcinoma: A Case Report 22
Foamy gland pancreatic ductal adenocarcinoma diagnosed on EUS-FNA: A histochemical, immunohistochemical, and molecular report 21
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 21
Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload 21
Cytology versus histology for programmed death-ligand 1 expression evaluation in the landscape of non-small cell lung cancer patients selection for immunotherapy 20
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 20
Identification of a New Pathway for Tumor Progression: MicroRNA-181b Up-Regulation and CBX7 Down-Regulation by HMGA1 Protein 19
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 18
A novel approach to classification and reporting of lymph node fine-needle cytology: Application of the proposed sydney system 18
A narrative review of predictive immuno-histo/cyto chemistry in lung cancer: focus on gene fusions and PD-L1 expression 16
Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer 16
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries 16
PD-L1 and beyond: Immuno-oncology in cytopathology 16
Tumor mutational burden on cytological samples: A pilot study 15
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic 15
Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience 15
Molecular predictive testing in precision oncology: The Italian experience 14
Juggling the COVID-19 pandemic: A cytopathology point of view 14
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 14
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 13
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 9
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 9
Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe 7
Pathology in non-small cell lung cancer: evolving scenario 7
Reference standards for gene fusion molecular assays on cytological samples: an international validation study 6
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 5
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers 1
Totale 1.467
Categoria #
all - tutte 6.287
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.287


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055 13 6 3 4 0 0 0 7 0 6 14 2
2020/2021180 1 0 10 2 4 44 8 28 31 25 20 7
2021/2022337 10 10 8 14 6 1 9 31 22 41 88 97
2022/2023515 50 21 26 31 77 65 1 48 85 43 58 10
2023/2024292 26 49 37 23 14 31 9 76 17 10 0 0
Totale 1.467